^
    Back
    Association details:
    Biomarker:SNHG1 deletion
    Cancer:Prostate Cancer
    Drug:docetaxel (Tubulin polymerization promoter, Microtubule stabilizer)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: D – Preclinical
    Source:
    AACR 2022
    Title:

    1544 / 13 - The lncRNA SNHG1 modulates quiescence and chemoresistance of prostate cancer

    Published date:
    03/09/2022
    Excerpt:
    These data show that SNHG1 plays a role in prostate cancer cell cycle...cells deficient in SNHG1 are more resistant to docetaxel.